Molecular-Targeted Therapies in Lung Cancer: Practical Application of Clinical Trials Data

July 10, 2021

This accredited continuing education activity “Molecular-Targeted Therapies in Lung Cancer: Practical applications of clinical trials data”, is a half-day conference featuring leading experts in lung cancer who will provide a comprehensive overview of implications of actionable molecular alterations in lung cancer. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for their patients with lung cancer. This program features in-depth discussions and analysis of the latest scientific findings and practice-changing advances (including the data presented at the 2021 ASCO Annual Meeting in June, 2021) in molecular testing and targeted-therapies for lung cancer. Expert faculty will utilize didactics, case-based presentations and related panel discussions, and aim to place molecular testing into clinical context and discuss how the results may effectively contribute to patient care. 

This educational activity will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:

  • Role of different platforms, including next generation sequencing, in testing for actionable molecular alterations to identify targeted therapy options in lung cancer. 
  • Current and evolving paradigms in a biomarker driven precision oncology approach for management of lung cancer.
  • Trends, challenges, controversies, and limitations of precision oncology approaches and targeted therapies in management of lung cancer. 

Target Audience

  • Oncologists
  • Oncology Nurse Practitioners & Physician Assistants 
  • Oncology Pharmacists
  • Oncology Nurses
  • Residents/Fellow
  • Researchers

REGISTRATION FEES

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-t employed by the industry" option when registering and the price will reset to $0

Healthcare providers ($0.00)

Industry employees ($206) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, please register for the course here

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant. 

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  1. Review the role, including advantages and disadvantages, of different testing methodologies available for detecting molecular alterations in lung cancer. 
  2. Interpret results of next generation sequencing and other biomarkers predictive of response to targeted therapies in lung cancer.
  3. Plan optimal molecular-targeted adjuvant and/or extended adjuvant strategies for patients with non-metastatic NSCLC.
  4. Integrate recent advances and available clinical data to optimally sequence molecular-targeted agents in the treatment of metastatic NSCLC. 
  5. Outline emerging research, the mechanism of action, and the role of novel molecular-targeted therapies in clinical investigation for patients with NSCLC .
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 3.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 3.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 3.50 Contact Hours.
  • 0.00 Participation
Course opens: 
06/13/2021
Course expires: 
12/31/2021
Event starts: 
07/10/2021 - 7:05am
Event ends: 
07/10/2021 - 12:30pm
Cost:
$1.00

All times are listed in Pacific Time zone


7:15 AM to 8:00 AM PST:     Registration/Networking 

Session 1: Moderator - Dr. Kumar Prabhash

8:00 AM to 8:20 AM PST:    Epidemiology of molecular alterations in lung cancer - Dr. Christina Merkhofer

8:20 AM to 9:15 AM PST:    Methodologies for detection of molecular driver mutations in lung cancer, a case-based discussion - Dr. Tejas Patil

9:15 AM to 9:45 AM PST:     Break

Session 2: Moderator - Dr. Tejas Patil 

9:45 AM to 10:10 AM PST:  Molecular-guided adjuvant therapy for lung cancer - Dr. Rafael Santana-Davila 

10:10 AM to 10:35 AM PST: Molecular-guided therapy for metastatic lung cancer: Targeting EGFR, ROS1, ALK and BRAF – Dr. Kathryn Gold 

10:35 AM to 11:00 AM PST: Molecular-guided therapy for metastatic lung cancer: Targeting MET, NTRK and RET - Dr. Wade Thomas Iams 

11:00 AM to 12:00 PM PST: Emerging precision oncology approaches in management of lung cancer, a case-based discussion - Dr. Narjust Duma 

12:00 PM PST: Adjourn 

 

Narjust Duma, MD

Assistant Professor of Medicine

Dana-Farber Cancer Institute/Harvard University 

Learn More

Cristina Merkhofer, MD

Assistant Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Kathryn Gold, MD

Associate Professor of Medicine

University of California, San Diego

Learn More

Tejas Patil, MD

Assistant Professor of Medicine

University of Colorado

Learn More

Wade Iams, MD

Assistant Professor of Medicine

Vanderbilt University 

Learn More

Rafael Santana-Davila, MD

Associate Professor of Medicine 

University of Washington

Medical Oncologist

Seattle Cancer Care Alliance 

Learn More

Kumar Prabhash, MD

Medical Oncologist

Tata Memorial Hospital, Mumbai, India

Learn More

  

 

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 3.5 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 3.5 Contact Hours.

ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Commercial Support Disclosure

This activity is supported with an Independent Medical Education Grant from Merck Sharp & Dohme Corp

Available Credit

  • 3.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 3.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 3.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 3.50 Contact Hours.
  • 0.00 Participation

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

Price

Cost:
$1.00
Please login or register to take this course.

Cancellation Policy

You may cancel your registration anytime. No refunds will be issued for cancelled registration. 

You must complete all required course objects to be able to claim continuing education (CE) credits or maintenance of certificate (MOC) points.

Required Hardware/software

This meeting will be held virtually. Registered attendees will be able to access the link to join the meeting by logging into their account and navigating to the "my pending activities" tab.

The meeting link will be activated 30-minutes before the activity start time.

 

Registration Fees

 

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-t employed by the industry" option when registering and the price will reset to $0

Healthcare providers ($0.00)

Industry employees ($206) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, please register for the course here

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.